Sarcomas are a type of tumor which develop from the connective tissues of the body. Connective tissues are cells that connect or support other tissues in the body. These tumors develop in the ...

Some patients who had disease progression after stopping larotrectinib achieved a response after resuming larotrectinib.

Patients with bone and soft tissue sarcomas are treated in the Baylor St. Luke's Medical Center Dan L Duncan Comprehensive Cancer Center by a multidisciplinary team of cancer experts. Orthopedic ...

The International Federation of Gynecology and Obstetrics (FIGO) staging systems for vulva, cervix, endometrium, and sarcomas have been revised for the first time in over a decade. The purpose of ...

Another significant area of research has been the combination of carotuximab, an anti-angiogenic agent, with pazopanib, a targeted therapy for soft tissue sarcomas. A phase 3 clinical trial found ...

which is an approved chemotherapeutic drug for certain advanced soft-tissue sarcomas (STS). Patients with STS could potentially benefit from an enhanced local immune response in the tumor ...

Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas Larotrectinib is a ...